Table 2.

Overview of the correlation between the advanced glycation end products (AGE)-specific fluorescence intensity at 440 nm and 490 nm and the investigated clinical parameters.

	Dependent Variable:Fluorescence Intensity
	Ln(440 nm)		Ln(490 nm)
Parameter	Correlation Coefficient	p-Value	Correlation Coefficient	p-Value
Age	0.3930	<0.0001	0.3806	<0.0001
BMI	0.1418	0.0480	0.1181	N.S.
Smoking	0.1728	0.0171	0.1938	0.0074
Ln(eGFR)	−0.3767	<0.0001	−0.3472	<0.0001
Ln(Urea)	0.1822	0.0199	0.1453	N.S.
Ln(CRP)	0.2416	0.0008	0.2210	0.0023
Hemoglobin	−0.1617	0.0392	−0.1489	N.S.
Treatment
Aspirin	0.1840	0.0110	0.1582	0.0293
Peroral anticoagulant	0.1711	0.0183	0.1464	0.0439
ACE inhibitor or ARB	0.1541	0.0337	0.1401	N.S.
Beta blocker	0.2023	0.0051	0.1724	0.0174
Nondihydropyridine calcium	0.1834	0.0113	0.1524	0.0358
channel blocker
Loop diuretic	0.2570	0.0003	0.2243	0.0019
Statin	0.2053	0.0045	0.1990	0.0059
Insulin	0.2793	0.0001	0.2386	0.0009
Vitamin D	0.1505	0.0382	0.1219	N.S.

Abbreviations: ACE, angiotensin converting enzyme; ARB, angiotensin II receptor blocker; CRP, C-reactive protein; eGFR, estimated glomerular filtration rate; N.S., not significant.